Clinical Trial Update: A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SM-01 stenting versus percutaneous transluminal angioplasty for superficial femoral artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• SM-01 Stenting

Snippet

Sponsor: Johnson & Johnson K.K. Medical Company | Conditions: Peripheral Vascular Diseases | Phase 3 | Status: COMPLETED